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Crystallographic and spectroscopic snapshots
reveal a dehydrogenase in action
Lu Huo1,2,*,w, Ian Davis1,2,*, Fange Liu1,w, Babak Andi3, Shingo Esaki1,2, Hiroaki Iwaki4, Yoshie Hasegawa4,
Allen M. Orville3,5 & Aimin Liu1,2

Aldehydes are ubiquitous intermediates in metabolic pathways and their innate reactivity can
often make them quite unstable. There are several aldehydic intermediates in the metabolic
pathway for tryptophan degradation that can decay into neuroactive compounds that have
been associated with numerous neurological diseases. An enzyme of this pathway,
2-aminomuconate-6-semialdehyde dehydrogenase, is responsible for ‘disarming’ the ﬁnal
aldehydic intermediate. Here we show the crystal structures of a bacterial analogue enzyme
in ﬁve catalytically relevant forms: resting state, one binary and two ternary complexes, and a
covalent, thioacyl intermediate. We also report the crystal structures of a tetrahedral,
thiohemiacetal intermediate, a thioacyl intermediate and an NAD þ -bound complex from an
active site mutant. These covalent intermediates are characterized by single-crystal and
solution-state electronic absorption spectroscopy. The crystal structures reveal that the
substrate undergoes an E/Z isomerization at the enzyme active site before an sp3-to-sp2
transition during enzyme-mediated oxidation.
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he dominant route of tryptophan catabolism, the kynurenine pathway, has recently garnered increased attention
given its apparent association with numerous inﬂammatory and neurological conditions, for example, gastrointestinal
disorders, depression, Parkinson’s disease, Alzheimer’s disease,
Huntington’s disease and AIDS dementia complex1–6. Though
the precise mechanism by which the kynurenine pathway
inﬂuences these diseases has not yet been fully elucidated, it has
been determined that several metabolites of this pathway are
neuroactive. Notably, the concentration of quinolinic acid, a nonenzymatically derived decay product of an intermediate of the
kynurenine pathway used for NAD þ biosynthesis, is elevated
over 20-fold in patients’ cerebrospinal ﬂuid with AIDS dementia
complex, aseptic meningitis, opportunistic infections or
neoplasms7, and more than 300-fold in the brain of human
immunodeﬁciency virus-infected patients8. This NAD þ
precursor has also been shown to be an agonist of N-methyl-Daspartate receptors, and an increase of its concentration may lead
to over-excitation and death of neuronal cells9,10.
The apparent medical potential of the kynurenine pathway
warrants detailed study and characterization of its component
enzymes and their regulation. One enzyme in particular,
2-aminomuconate-6-semialdehyde dehydrogenase (AMSDH), is
responsible for oxidizing the unstable metabolic intermediate
2-aminomuconate-6-semialdehyde (2-AMS) to 2-aminomuconate (2-AM) (Fig. 1a). On the basis of sequence alignment,
AMSDH is a member of the hydroxymuconic-semialdehyde
dehydrogenase (HMSDH) family under the aldehyde dehydrogenase (ALDH) superfamily11. ALDHs are prevalent in both
prokaryotic and eukaryotic organisms and are responsible for
oxidizing aldehydes to their corresponding carboxylic acids. They
use NAD(P) þ as a hydride acceptor to harvest energy from their
primary substrate and generate NAD(P)H, which provides the
major reducing power to maintain cellular redox balance12,13. In
addition to being commonly occurring metabolic intermediates,
aldehydes are reactive electrophiles, making many of them toxic.
Enzymes of the ALDH superfamily are typically promiscuous
with regards to their substrates; however, in recent years, this
superfamily has had several new members identiﬁed with greater
substrate ﬁdelity, especially when the substrate is identiﬁed as a
semialdehyde14.
The putative native substrate of AMSDH, 2-AMS, is a
proposed metabolic intermediate in both the 2-nitrobenzoic acid
degradation pathway of Pseudomonas ﬂuorescens KU-7 (ref. 15)
and the kynurenine pathway for L-tryptophan catabolism in
mammals9,10,16. In the presence of NAD þ and AMSDH, 2-AMS
is oxidized to 2-AM (Fig. 1a); however, it can also spontaneously
decay to picolinic acid and water with a half-life of 35 s at neutral
pH17. Due to its instability, 2-AMS has not yet been isolated,
leaving its identity as the substrate of AMSDH an inference
based on decay products and further metabolic reactions.
There are several reasons for the poor understanding of this
pathway: it is complex with many branches, some of the
intermediates are unstable and difﬁcult to characterize, and
several enzymes of the pathway, including AMSDH, are not well
understood. Hence, the structure of AMSDH will help to address
questions such as what contributes to substrate speciﬁcity for the
semialdehyde dehydrogenase and how 2-AMS is bound and
activated during catalysis.
In the present study, we have cloned AMSDH from
Pseudomonas ﬂuorescens, generated an E. coli overexpression
system and puriﬁed the target protein for molecular study. We
also constructed several mutant expression systems to characterize the role of speciﬁc active site residues. Enzymatic assays were
performed for all forms of the enzyme, and crystal structures were
solved for the wild type and one mutant. We were able to capture
2

several catalytic intermediates in crystallo by soaking protein
crystals in mother liquor containing either the primary organic
substrate or a substrate analogue and discovered that in addition
to dehydrogenation, the substrate undergoes isomerization at the
active site.
Results
Catalytic activity of wild-type AMSDH. Due to the unstable
nature of its substrate, 2-AMS, the activity of AMSDH was
detected using a coupled-enzyme assay that employed its upstream
partner, a-amino b-carboxymuconate e-semialdehyde decarboxylase (ACMSD), to generate 2-AMS in situ. ACMSD transforms
a-amino b-carboxymuconate e-semialdehyde (ACMS) (lmax at
360 nm) to 2-AMS (lmax at 380 nm)16,17. As seen in Fig. 1b, in an
assay that uses only ACMSD, the absorbance peak of its substrate,
ACMS, red-shifts to 380 nm as 2-AMS is formed. The absorbance
at 380 nm then quickly decreases as 2-AMS decays to picolinic
acid, a compound with no absorbance features above 200 nm. In a
coupled-enzyme assay, ACMSD, AMSDH and NAD þ are
included in the reaction system. As shown in Fig. 1c, ACMS
is still consumed; however, there is no red shift observed because
2-AMS is enzymatically converted to 2-AM (lmax at 325 nm)
rather than accumulating and decaying to picolinic acid. The
production of 2-AM requires that an equimolar amount of NAD þ
be reduced to NADH (lmax at 339 nm). A stable alternative
substrate, 2-hydroxymuconate-6-semialdehyde (2-HMS), was
used to pursue kinetic parameters (Fig. 1d), when using
saturating NAD þ concentrations (Z1 mM), the kcat and Km of
AMSDH for 2-HMS were 1.30±0.01 s  1 and 10.4±0.2 mM,
respectively (Fig. 1e).
Structural snapshots of the dehydrogenase catalytic cycle. We
solved ﬁve crystal structures of wild-type AMSDH, including the
ligand-free (2.20 Å resolution), NAD þ -bound binary complex
(2.00 Å), ternary complex with NAD þ and substrate 2-AMS
(2.00 Å) or 2-HMS (2.20 Å) and a thioacyl intermediate (1.95 Å).
All ﬁve structures belong to space group P212121. Data collection
and reﬁnement statistics are listed in Supplementary Table 1. The
complete AMSDH model includes four polypeptides per asymmetric unit describing one homotetramer (Supplementary
Fig. 1a). Each monomer of AMSDH contains three domains: a
subunit interaction domain, a catalytic domain and an NAD þ
binding domain (Supplementary Fig. 1b). For details of the secondary structure, see Supplementary Discussion.
In the structure of the co-crystallized binary complex, an
NAD þ molecule is present in an extended, anti-conformation in
the amino-terminal, co-substrate-binding domain of each monomer (Fig. 2a). The electron density map of NAD þ is well deﬁned,
and the interactions between the protein and NAD þ are
equivalent in all four subunits as shown in Fig. 2e. The NAD þ bound AMSDH structure is similar to the ligand-free structure
with an aligned r.m.s.d. of 0.239 Å. Residues that belong to the
NAD þ -binding pocket are also well aligned with the exception of
Cys302, Arg108 and Leu116 (Supplementary Fig. 2). On binding
NAD þ , the thiol moiety of Cys302 rotates so that the sulfur is
2.3 Å closer to the substrate-binding pocket and away from the
nicotinamide head of NAD þ .
Crystal structures of enzyme–substrate ternary complexes.
Structures of AMSDH in ternary complex with co-substrate
NAD þ and its primary substrates were obtained by soaking cocrystallized AMSDH-NAD þ crystals with 2-AMS and 2-HMS,
respectively. Extra density that ﬁts with the corresponding substrate molecule was observed in the active site of each subunit.
The co-substrate NAD þ in the ternary complex structures is
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Figure 1 | Activity of AMSDH. (a) Reaction scheme showing the enzymatic generation of 2-AMS, the reaction catalysed by AMSDH, and the
competing non-enzymatic decay of 2-AMS to picolinic acid. (b) Representative assay showing the ACMSD (1 mM)-catalysed conversion of ACMS (lmax
360 nm) to 2-AMS (lmax 380 nm), which decays to picolinic acid (transparent). (c) Coupled-enzyme assay in which AMSDH (200 nM) oxidizes 2-AMS,
produced in situ as shown in b in 50 s, to 2-AM (lmax 325 nm). (d) Reaction scheme showing 2-HMS oxidation by AMSDH. (e) Representative assay
showing the activity of AMSDH (200 nM) on 2-HMS (lmax 375 nm) in 50 s. The inset is a Michaelis–Menten plot.

bound in the same manner as in the binary complex. Binding of
the primary substrates introduced minimal change to the protein
structure; the r.m.s.d. for the superimposed structures of substrate-free with 2-AMS- and 2-HMS-bound ternary complex
structures are 0.170 and 0.276 Å, respectively. These two primary
substrates bind to AMSDH in an identical fashion, with two
arginine residues, Arg120 and Arg464, playing an important role
in stabilizing the substrate by forming two sets of bifurcated
hydrogen bonds with one of the carboxyl oxygens and the
2-amino or hydroxyl group of 2-AMS (Fig. 2b) or 2-HMS
(Fig. 2c), respectively. The observation of two hydrogen bonds
being donated by the active site arginines to the 2-amino group of
2-AMS indicates that in the substrate-bound form, 2-AMS may
be in its 2-imine rather than 2-enamine tautomer, as an amino
group unlikely to accept two hydrogen bonds. Mutation of
Arg120 to alanine causes a moderate decrease of the kcat to
0.7±0.2 s  1 from 1.30±0.01 s  1 and a dramatic increase of
the Km with a lower bound of 446.3±195.9 mM (an accurate
determination of the Km is hindered by insufﬁcient 2-HMS
concentrations) compared with 10.4±0.2 mM in the wild type
(Supplementary Fig. 3a). Mutation of Arg464 to alanine
decreased the kcat to B0.3 s  1, and not only increased the Km to
B170 mM, but also leads to a signiﬁcant substrate inhibition
effect with a Ki of B6 mM (Supplementary Fig. 3b). This substrate
inhibition is likely caused by the unproductive binding of a second substrate molecule in the space created by the deletion of

Arg464 or by a failure of the enzyme to properly bind and stabilize the imine form of the substrate.
Catalytic intermediates trapped after ternary complex formation.
Enzyme–NAD þ binary complex crystals were soaked in mother
liquor containing 2-HMS for a range of time points
from 5 min to more than 3 h before ﬂash cooling in liquid
nitrogen. In a crystal that was soaked for 40 min, an
intermediate was trapped and reﬁned to a resolution of 1.95 Å
(Fig. 2d). Crystals soaked for longer time points gave a similar
intermediate with poorer resolution. In this structure, 2-HMS is
observed in the 2Z, 4E isomer rather than the 2E, 4E isomer
as seen in the substrate-bound ternary structure. Also, the
substrate interacts with Arg120 and Arg464 with both of its
carboxyl oxygens rather than one carboxyl oxygen and the
2-hydroxy oxygen as shown in the 2-HMS ternary complex
structure. Fitting this density with the 2E, 4E conformation
resulted in unsatisfactory 2Fo  Fc and Fo  Fc density maps
as shown in Supplementary Fig. 4a. Likewise, attempting to ﬁt
the 2Z, 4E isomer to the ternary complex structure did
not produce satisfactory results (Supplementary Fig. 4b).
On E to Z isomerization, the carbon chain of the substrate
extends, and the distance between its sixth carbon and Cys302’s
sulfur is now at 1.8 Å, which is within covalent bond distance for
a carbon–sulfur bond. Also, the continuous electron density
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Figure 2 | Crystal structures of wild-type AMSDH and single-crystal electronic absorption spectrum of a catalytic intermediate. AMSDH was
co-crystallized with NAD þ to give AMSDH-NAD þ binary complex crystals that were used for soaking experiments. (a) Active site structure of the binary
AMSDH-NAD þ complex, (b) the ternary complex of AMSDH-NAD þ crystals soaked with 2-AMS for 5 min before ﬂash cooling, (c) the ternary
complex of AMSDH-NAD þ soaked with 2-HMS for 10 min before ﬂash cooling, (d) the trapped thioacyl, NADH-bound intermediate obtained by soaking
AMSDH-NAD þ crystals with 2-HMS for 40 min before ﬂash cooling. (e) Two-dimensional interaction diagram for NAD þ binding. (f) Close-up of the
thioacyl intermediate in d. (g) Single-crystal electronic absorption spectrum of d. Protein backbone and residues are shown as light blue cartoons and
sticks, respectively. The substrates and intermediate are shown as yellow sticks, and NAD þ and NADH are shown as green sticks. The omit map for
ligands is contoured to 2.0 s and shown as a grey mesh.

between Cys302-SG and 2-HMS-C6 indicates the presence of a
covalent bond (Fig. 2f). Another feature of this intermediate is
that the nicotinamide ring of NAD þ has moved 4.6 Å away
from the active site and adopted a bent conformation (Fig. 2d)
compared with the position in the binary or ternary complex
structures (Fig. 2a–c). The structural changes of NAD þ associated with reduction has been observed and well documented18,19. In the oxidized state, NAD(P) þ lies in the
Rossmann fold in an extended conformation, allowing for
hydride transfer from the substrate to its nicotinamide carbon
during the ﬁrst half of the reaction. Reduced NAD(P)H then
adopts a bent conformation in which the nicotinamide head
moves back towards the protein surface. This movement
provides more space in the active site for the second half of
the reaction, acyl-enzyme adduct hydrolysis, to take place. Thus,
the coenzyme in this intermediate structure is likely to have been
reduced to NADH and, as such, the structure is assigned as a
thioacyl-enzyme–substrate adduct. The single-crystal electronic
absorption spectrum of the sample has an absorbance maximum
at 394 nm (Fig. 2g). The same absorbance band was observed in
crystals soaked with 2-HMS from 30 min to 2 h (Supplementary
Fig. 5a). However, this long-lived intermediate in the crystal was
not observed in solution with millisecond-to-second time
resolution in stopped-ﬂow experiments (Supplementary
Fig. 6a). Thus, it is either present in an earlier time domain
4

(sub-milliseconds), or alternatively, it may not accumulate in
solution because NADH can readily dissociate in solution,
whereas it may be trapped in the active site when in the
crystalline state.
Another notable change in the intermediate structure is the
movement of the side chain of Glu268, which rotates 73° towards
the active site (Fig. 2c,d). To probe the function of Glu268, we
constructed an alanine mutant and found that it exhibited no
detectable activity in steady-state kinetic assays. Interestingly,
E268A exhibits completely different pre-steady state activity than
the wild-type enzyme. As shown in Supplementary Fig. 6b, an
absorbance band at 422 nm was formed concomitant with the
decay of the 2-HMS peak within 1 s of the reaction. This new
species is generated stoichiometrically on titration of 2-HMS with
E268A (Fig. 3d). The moiety that gives rise to this new
absorbance band is stable for minutes at room temperature and
cannot be separated from the protein by membrane ﬁltrationbased methods20, suggesting that it is covalently bound to the
protein. The formation of an enzyme–substrate adduct in the
E268A mutant was investigated by mass spectrometry. For the asisolated E268A, the resultant multiply charged states
(Supplementary Fig. 7) were deconvoluted to obtain a
molecular weight (MW) of 56,252 Da (Fig. 4a). This value is in
good agreement with the predicted MW of E268A AMSDH plus
an amino-terminal His-tag and linking residues, 56,251 Da. The
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Figure 3 | Crystal structures of the E268A mutant and its solution and single-crystal electronic absorption spectra. (a) Structure of the active site of
the co-crystallized E268A-NAD þ binary complex, (b) a thiohemiacetal intermediate obtained by soaking the E268A-NAD þ crystals with 2-HMS for
30 min before ﬂash cooling and (c) a thioacyl intermediate obtained by soaking the E268A-NAD þ crystals with 2-HMS for 180 min before ﬂash cooling.
(d) Solution electronic absorption spectra of a titration of 2-HMS with E268A. (e) Single-crystal electronic absorption spectrum of the intermediate in b
(top panel) and single-crystal electronic absorption spectrum of the intermediate in c (bottom panel). Protein backbone and residues are shown as
light blue cartoons and sticks, respectively. The substrate and intermediate are shown as yellow sticks, and NAD þ and NADH are shown as green sticks.
The omit map for ligands is contoured to 2.0 s and shown as a grey mesh.
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second largest peak in the deconvoluted spectrum has a MW
177 Da greater than that of the most abundant signal. This is
likely due to post-translational modiﬁcation of the His-tag; a-NGluconoylation of His-tags has been observed in E. coli-expressed
proteins, which cause 178 Da extra mass21. The mutant protein
was then treated with the alternate substrate, 2-HMS, and the
mass spectrum shows a new major peak at 56,390 Da (Fig. 4b),
138 Da heavier than the as-isolated mutant. Similarly, the second
most abundant peak corresponds to a His-tag modiﬁed mutant
plus 139 Da. In this spectrum, the peaks arising from the asisolated mutant are substantially reduced, indicating that 2-HMS,
141 Da, is bound to the E268A mutant enzyme.
We determined the crystal structure of E268A co-crystallized
with NAD þ and reﬁned it to 2.00 Å resolution (Fig. 3a). The

overall structure aligns very well with the wild-type binary
complex structure with an r.m.s.d. of 0.139 Å. The active site of
E268A also resembles the native AMSDH structure
(Supplementary Fig. 8). The nature of the absorbing species at
422 nm was further investigated by soaking co-crystallized
E268A-NAD þ crystals in mother liquor containing 2-HMS. By
doing so, two temporally, structurally and spectroscopically
distinct intermediates were identiﬁed.
When E268A-NAD þ crystals are soaked with 2-HMS for
40 min or less, their single-crystal electronic absorption spectra
show an absorbance maximum at 422 nm (Supplementary
Fig. 5b), as was observed in the solution-state titration and the
stopped-ﬂow assays. An individual electronic absorption spectrum for an E268A-NAD þ crystal soaked with 2-HMS for
15 min can be found in Fig. 3e (top). The structure of E268ANAD þ soaked with 2-HMS for 30 min before ﬂash cooling was
solved and reﬁned to 2.15 Å resolution (Fig. 3b). In this structure,
a continuous electron density between Cys302-SG and 2-HMSC6 is observed, similar to the thioacyl intermediate observed in
the wild-type enzyme. However, in contrast to the thioacyl
intermediate, the density around C6 is less ﬂat, indicating an
sp3- rather than sp2-hybridized carbon (Fig. 5a). The angle
between the plane of the carbon backbone of the substrate and
the formerly aldehydic oxygen is 55±9°, compared with the
angle of the wild-type thioacyl intermediate at 26±4°
(Supplementary Table 2). More importantly, the C6 of 2-HMS
and the C4N of NAD þ are very close (2.4–2.8 Å), making
it unlikely that the hydride has been transferred from the
substrate. Taken together, these data allow us to assign this
intermediate to a thiohemiacetal enzyme adduct (Fig. 3b).
A similar intermediate has only been trapped once previously
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Investigation of isomerization by computational modelling.
The isomerization of 2-AMS from the 2E to 2Z isomer implied by
the solved crystal structures was probed with density functional
theory calculations. The free energy proﬁles obtained were used
to help illuminate the nature of 2-AMS and gain insight into how
the active site of AMSDH may facilitate the isomerization. The
total energies of different isomers and rotamers of 2-AMS in its
enamine/aldehyde and imine/eneol tautomers and the rotational
barriers about their respective 2–3 bond were compared. For the
imine/eneol tautomer, additional computations were performed
with the side groups from Arg120 and Arg464 to investigate what
effect, if any, they will have on the free energy proﬁle for rotation
about the 2–3 bond of 2-AMS.
First, 2-AMS was constructed and optimized in its 2-enamine,
6-aldehyde, 2E isomer with a negatively charged 2-carboxylate
group (Fig. 6a). To estimate the energy barrier for an uncatalysed
6
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in a crystal that contains no co-substrate22. Hence, this is the
ﬁrst time for this intermediate to be trapped in the presence
of NAD þ .
If the E268A-NAD þ crystals are soaked with 2-HMS for
longer than 1 h, their single-crystal electronic absorption
spectra begin to resemble that of the wild-type, thioacyl
intermediate with a corresponding absorbance maximum at
394 nm (Supplementary Fig. 5b), as seen in wild-type, thioacyl
intermediate crystals. An individual electronic absorption spectrum for an E268A-NAD þ crystal soaked with 2-HMS for
120 min can be found in Fig. 3e (bottom). The structure of an
E268A-NAD þ crystal soaked with 2-HMS for 180 min was
solved and reﬁned to 2.20 Å (Fig. 3c). The structure of this
intermediate is also similar to the wild-type, thioacyl-enzyme
adduct with NADH, rather than NAD þ found at the active site.
The distance between the C4N of NADH and C6 of 2-HMS is
longer than 6.1 Å (Fig. 3c). The electron density around C6 is
ﬂatter (Fig. 5b) compared with the thiohemiacetal intermediate
and similar to the thioacyl intermediate trapped in the wild-type
AMSDH structure (Fig. 2f), and the angle between the plane of
the carbon backbone of the substrate and the carbonyl oxygen is
20±5°, which is statistically indistinguishable from that of the
wild-type, thioacyl intermediate, 26±4° (Supplementary
Table 2). On the basis of the similarities in their absorbance
and structures, we conclude that this latter intermediate is
equivalent to the wild-type, thioacyl intermediate. It is also worth
noting that the strictly conserved asparagine 169 (Fig. 5) is seen to
stabilize both the thiohemiacetal and thioacyl intermediates
through hydrogen-bonding interactions.

ΔG = 1.7 kcal mol–1

‘Z-like’

‘E-like’
Dihedral angle

Figure 6 | Free energy proﬁles for the rotation about the 2–3 bond of
2-AMS in its (a) enamine and (b) imine form, respectively. DFT
calculations were performed at the B3LYP/6-31G* þ level of theory. The
dihedral angle about the 2–3 bond was restrained in 10° increments and the
structures were optimized at each point.
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isomerization from the 2E to the 2Z isomer, the 2–3 double bond
was then restrained at 10° intervals from 180 to 0°, and the
structure was optimized at each point. On the basis of the free
energy proﬁle (Fig. 6a), the uncatalysed isomerization barrier is
31.9 kcal mol  1. The proﬁle also shows that the 2Z isomer, as
might be expected, is lower in energy than the 2E isomer by
4.2 kcal mol  1. Next, the rotational barrier about the 2–3 bond of
2-AMS when in its 2-imine, 6-enol tautomer, as is suggested by
the ternary complex structure, was calculated in the same
manner. The barrier was found to be 9.2 kcal mol  1, and
opposite to the enamine tautomer, the ‘2Z-like’ rotamer is higher
in energy than the ‘2E-like’ rotamer by 1.7 kcal mol  1 (Fig. 6b).
Unsurprisingly, the rotational barrier about the 2–3 bond is much
lower in the imine tautomer; however, the ‘2Z-like’ rotamer of the
imine tautomer is 21.8 kcal mol  1 higher in energy than the 2Z
isomer of the enamine tautomer.
Possible inﬂuences of the two active site arginines on the free
energy proﬁle for rotation were also considered. To mimic the
conditions of the enzyme active site, similar calculations as those
above were performed, which included the guanidinium heads of
Arg120 and Arg464. The starting model was built using the active
site geometry of the ternary complex crystal structure (PDB entry:
4I25), and on inspection, it is immediately apparent that with two
arginines in such close proximity to the substrate, there is
insufﬁcient space for two hydrogen atoms on the nitrogen at the
2-position of 2-AMS, and attempts to optimize an enamine
tautomer with the hydrogen-bonding pattern of the ternary
complex produced structures within which the entire 2-AMS
molecule rotates so that only the carboxylate group interacts with
the guanidinium moieties. The absolute positions of the
guanidinium groups were ﬁxed and the structure of 2-AMS in
the imine tautomer was optimized. The dihedral angle of the 2–3
bond of 2-AMS was then increased in 45° increments and the
structure optimized while restraining the position of the
guanidinium groups and the 2–3 bond to build a rough free
energy proﬁle to estimate the rotational barrier. In the presence of
the active site arginines, the barrier about the 2–3 bond of 2-AMS
is further reduced to 8.5 kcal mol  1 (Supplementary Table 3).
Another interesting ﬁnding is that in the presence of the
guanidinium groups, the ‘2E-like’ and ‘2Z-like’ rotamers of
2-AMS are nearly isoenergetic, with a free energy difference
of 0.2 kcal mol  1 (Supplementary Table 3).
Discussion
The substrate of AMSDH, 2-AMS, contains an unstable aldehyde
in conjugation with an enamine and can decay to picolinic acid
and water, presumably through an electrocyclization reaction
similar to its metabolic precursor, ACMS23. To assay the
enzymatic activity, the upstream enzyme was utilized in the
reaction mixture to generate substrate, and it was shown that
AMSDH is catalytically active. Unfortunately, no kinetic
parameters can be reliably determined because the
concentration of 2-AMS is not well deﬁned in the coupledenzyme assay. To circumvent this issue, a previously-identiﬁed,
stable alternative substrate, 2-HMS24,25, in which a hydroxyl
group replaces the amino group in 2-AMS to prevent cyclization,
was used to characterize the activity of AMSDH and to examine
the activity of the mutants.
Substrate-bound, ternary complex structures were obtained by
soaking co-crystallized protein and NAD þ with 2-AMS or
2-HMS. 2-AMS is an unstable compound which decays with a t1/2
of about 9 s at pH 7.5 and 37 °C or 35 s at pH 7.0 and 20 °C.
Notably, this is its ﬁrst reported structure. It appears to be
stabilized in the enzyme active site in its imine tautomer by
forming two sets of bifurcated hydrogen bonds with Arg120 and

Arg464 so that the electrocyclization reaction cannot occur. Both
arginine residues are close to the protein surface and in good
positions to serve as gatekeepers, bringing the substrate into the
active site. As a residue residing on a loop, Arg464 should be
relatively ﬂexible. The electron density for the side chain of
Arg120 is partially missing in the binary complex structure but
very well resolved in both ternary complex structures. This
observation indicates that the presence of substrate can stabilize
what may be a ﬂexible residue. It becomes evident from the
coordinates that Arg120 and Arg464 play an important role in
substrate recognition, stabilization and possibly product release.
Two arginine residues are rarely observed in such close proximity,
stabilizing one end of the same molecule with multiple hydrogen
bonds. With the exception of the hydrogen bonds provided by
Arg120 and 464, the substrate-binding pocket is mostly
composed of hydrophobic residues. On the basis of sequence
alignment (Supplementary Fig. 9), these two arginine residues are
strictly conserved throughout the HMSDH family but are not
found in other members of the ALDH superfamily. We propose
that these dual arginines combined with the size restrictions
provided by the hydrophobic pocket endow this enzyme with its
speciﬁcity towards small a-substituted carboxylic acids with an
aldehyde moiety, such as 2-AMS and 2-HMS. Furthermore, our
computational work suggests that these arginines are crucial for
stabilizing the imine tautomer of 2-AMS to allow for rotation
about its 2–3 bond.
Two strictly conserved catalytic residues, Cys302 and Glu268,
are present at the interior of the substrate-binding pocket.
General features regarding these residues in the ALDH superfamily are (1) that the cysteine serves as a catalytic nucleophile,
which is anticipated to form a covalent-adduct intermediate with
the substrate by a nucleophilic addition during catalysis26–28 and
(2) that the glutamate serves as a base to activate water for
hydrolysis of the thioacyl-enzyme adduct29–32. Previous studies
indicate that the catalytic cysteine can adopt two conformations,
resting and attacking19. In the ligand-free structure, Cys302 is far
from where the carbonyl carbon of the substrate should be and is
in the resting state. In the ternary complex structures, Cys302 is
located at an ideal position to initiate catalysis, which is the
attacking state. It is proposed to attack the aldehydic carbon (C6)
of the substrate. In the two ternary complex structures, the
distance between the sulfur of Cys302 and the C6 of the substrate
is B3.3 Å. Cys302 and the aldehydic carbon form a covalent
bond in both thioacyl and thiohemiacetal intermediates.
Mutation of Cys302 to serine led to enzyme with no detectable
dehydrogenase activity, further conﬁrming its catalytic
signiﬁcance.
Examining the wild-type AMSDH structures shows that in the
NAD þ -bound binary complex, Glu268 adopts a ‘passive’
conformation, pointing away from the substrate-binding pocket,
and forms hydrogen bonds with both NE of Trp177 (3.2 Å
distance) and the backbone oxygen of Phe470 (3.6 Å) to leave
space for the reduction of NAD þ . Its electron density is very well
resolved and the side chain B-factor is close to average: 28.2 Å2/
28.5 Å2. The thiol moiety of Cys302 is 7.14 Å from Glu268 and is
unlikely to form interactions. Interestingly, in both substratebound structures, Glu268 becomes more ﬂexible and exhibits
much weaker electron density and increased side chain B-factors
compared with average protein B-factors: 37.8 Å2/28.5 Å2 and
66.37 Å2/39.7 Å2. In the thioacyl intermediate structure, the
electron density of Glu268 becomes very well deﬁned again, but
its side chain rotates 73° towards the bound substrate and seems to
be in an ‘active’ position to abstract a proton from a deacylating
water (Fig. 2d). At this point in the reaction cycle, the NADH
molecule needs to leave the active site to make room for the
catalytic water molecule. Movement of the nicotinamide ring of
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NAD þ coupled with the rotation of an active site glutamate has
previously been observed in other ALDHs during catalysis30–32.
Mutation of Glu268 to alanine led to the accumulation of the
thiohemiacetal intermediate in both solution and crystalline
states. The strictly conserved glutamate residue in the active site
of ALDH enzymes has been proposed to play up to three possible
roles during catalysis. It is strictly required to activate the
deacylating water that allows for product release, it is in a ‘passive’
conformation during NAD(P) þ reduction, and in some cases, it
may serve to activate cysteine for nucleophilic attack33. On the
basis of these roles, mutation to alanine would be expected to
decrease the rate of hydrolysis of the thioacyl adduct, have no
effect on the rate of reduction of NADH and possibly decrease the
rate of nucleophilic attack by cysteine. With this understanding,
deletion of the active site glutamate should cause an accumulation
of the thioacyl intermediate. However, in this work, the E268A
mutant is shown to accumulate the preceding thiohemiacetal
intermediate both in crystal and in solution. This ﬁnding suggests
an additional catalytic role for this residue: rotation of Glu268
towards the active site facilitates the hydride transfer from the
tetrahedral thiohemiacetal adduct to NAD þ . The rapid
formation of the intermediate in solution indicates that Glu268
of AMSDH does not play a role in activating cysteine. However, it
does appear necessary to complete hydride transfer from the
substrate to NAD þ , and its removal turns the native, primary
substrate into a suicide inhibitor.
On the basis of previous studies of the ALDH mechanism, the
eight high-resolution crystal structures solved (Supplementary
Table 1) as well as our biochemical and computational studies, we
propose a catalytic mechanism for AMSDH. As shown in Fig. 7,
NAD þ binds to the enzyme, 1, to form an NAD þ -bound
AMSDH complex, 2. The substrate, 2-AMS, is then recognized by
Arg120 and Arg464 through multiple hydrogen-bonding interactions, and its imine tautomer is stabilized in the active site, 3. At
this point, the order of the rotation, tautomerization and
nucleophilic attack by C302 on the aldehydic carbon to produce
O–

NAD+

OH

O

–O

AMSDH

NAD+ - AMSDH

1

2

O

NH2

the tetrahedral, thiohemiacetal intermediate, 4, is not yet clear.
The isomerization and nucleophilic attack drive a translation of
the substrate away from Arg120 and Arg464 so that they are only
able to interact with the carboxylate group of the substrate. Next,
NAD þ is reduced to NADH by abstraction of a hydride from 4,
forming a thioacyl intermediate, 5, a process which involves an
sp3-to-sp2 transition during oxidation of the organic substrate by
NAD þ . On reduction, the nicotinamide portion of NADH
moves away from the substrate as Glu268 rotates into position to
activate a water molecule to perform a nucleophilic attack on the
same carbon that was previously attacked by Cys302, forming a
second tetrahedral intermediate, 6. Finally, the second tetrahedral
intermediate collapses, breaking the C–S bond and releasing the
ﬁnal products, 2-AM and NADH. Species 1–5 are spectroscopically and structurally characterized, while intermediate 6
was not seen to accumulate.
In this work, ﬁve catalytically relevant structures of the wildtype AMSDH and three mutant structures yield a comprehensive
understanding of the protein’s overall structure, co-substratebinding mode and elucidate the primary residues responsible for
substrate speciﬁcity among the HMSDH family of the ALDH
superfamily. The structural and spectroscopic snapshots capture
the crystal structure of an unstable kynurenine metabolite,
2-AMS, and two catalytic intermediates, including stabilizing a
tetrahedral intermediate in a mutant protein, which was further
veriﬁed by mass spectrometry. Capture of a thiohemiacetal
intermediate upon deletion of E268 also points to a new role for
this well-established active site base in hydride transfer from
the substrate to NAD þ . Another interesting ﬁnding revealed
through solving the ternary complex and intermediate crystal
structures and supported by computational studies is that an E to
Z isomerization of the substrate occurs in this dehydrogenase
before hydride transfer. To the best of our knowledge, this is the
ﬁrst piece of structural evidence illustrating an ALDH
that proceeds via an E/Z isomerization of its substrate during
catalysis.
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Figure 7 | Proposed catalytic mechanism for the oxidation of 2-AMS by AMSDH. The primary substrate (2E, 4E)-2-aminomuconate-semialdehyde binds
to the enzyme in its imine tautomer to form the ternary complex (3). An isomerization and attack by cysteine on the aldehydic carbon form the (2Z, 4E)-2aminomuconate-thiohemiacetal adduct (4). AMSDH-mediated oxidation of 4 concomitant with reduction of NAD þ to NADH follows, generating a
thioacyl-enzyme intermediate (5). Both 4 and 5 are the catalytic intermediates covalently attached to the enzyme. Hydrolysis of 5 then allows the release
of the products 2-AM and NADH, restoring the ligand-free enzyme for the next catalytic cycle.
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Methods
General methods. The cloning, expression, puriﬁcation and site-directed mutagenesis of AMSDH are described in the Supplementary Methods.
Preparation of ACMS and 2-HMS. ACMS was generated by catalysing the
insertion of molecular oxygen to 3-hydroxyanthranilic acid by puriﬁed, Fe2 þ
reconstituted 3-hydroxyanthranilate 3,4-dioxygenase as described previously16,20.
2-HMS is generated non-enzymatically from ACMS following a previously
established method24. The pH of solutions containing ACMS was adjusted to B2 by
the addition of hydrochloric acid. 2-HMS formation was monitored on an Agilent
8453 diode-array spectrophotometer at 315 nm. The solutions were then neutralized
with sodium hydroxide once the absorbance at 315 nm stopped increasing. 2-HMS
at neutral pH has a maximum absorbance at 375 nm (ref. 24).

solarization-resistant optical ﬁbres with an internal diameter of 115, 230, 400 or
600 mm (Ocean Optics, Dunedin, FL). The other end was connected to a 40-mm
diameter, 35 mm working distance 4  , Schwardchild design reﬂective microscope
objective (Optique Peter, Lentilly France). The spectroscopy spot size is a
convolution of the optical ﬁbre diameter and the magniﬁcation of the objective,
which in this case produced 28, 50, 100 or 150 mm diameter spots, respectively.
Photons that passed through the crystal were collected with a second, aligned
objective that was connected to a similar optical ﬁbre or one with a slightly
larger internal diameter. The spectrum was then recorded with either an Ocean
Optics USB4000 or QE65000 spectrometer. Anisotropic spectra and an image of
the crystal/loop were collected as a function of rotation angle in 5° increments.
These were analysed by XREC37 to determine the ﬂat face and optimum
orientation.

Enzyme activity assay using 2-HMS as substrate. Steady-state kinetics analyses
were carried out at room temperature on an Agilent 8453 diode-array spectrophotometer. Reaction buffer contains 25 mM HEPES and 1 mM NAD þ , pH 7.5.
Consumption of 2-HMS by 200 nM AMSDH was detected by monitoring the
decrease of its absorbance at 375 nm with a molar extinction coefﬁcient of
43,000 M  1cm  1 (ref. 24) for 15 s with a 0.5 s integration time. For mutants,
700 nM protein and a wavelength of 420 nm, e420 11,180 M  1cm  1, was used.
Absorbance at 375 nm decreased and blue shifted to 295 nm, the maximum
ultraviolet absorbance for the product, 2-hydroxymuconic acid. This is consistent
with previous reports in which the ending compound was puriﬁed and veriﬁed as
the correct product24. The pre-steady state spectra were obtained with an Applied
Photophysics Stopped-Flow Spectrometer SX20 (UK) with the mixing unit hosted
inside an anaerobic chamber made by Coy Laboratory Products (MI, USA). Presteady state activity used the same reaction buffer but with 23 mM AMSDH or
E268A and 25 mM 2-HMS and were carried out at 10 °C. The change in absorbance
was monitored for 1.0 s.

Mass spectrometry. To prepare samples for ESI mass spectrometry, as-isolated
E268A AMSDH was buffer-exchanged to 10 mM Tris (pH 8.0) by running through
a desalting column (GE Healthcare). Intermediate bound E268A was obtained
by mixing E268A with 3 equiv. of 2-HMS. Excess 2-HMS was removed by
desalting chromatography using the same buffer. Desalted proteins were concentrated to a ﬁnal concentration of 20 mM. Freshly prepared samples were rinsed
by acetonitrile and 0.1% formic acid (1:1 ratio) before injection. Mass spectrometry
experiments were conducted using a Waters (Milford, MA) Micromass Q-TOF
micro (ESI-Q-TOF) instrument operating in positive mode. The capillary
voltage was set to 3,500 V, the sample cone voltage to 35 V and the extraction cone
voltage to 2 V. The source block temperature and the desolvation temperature were
set to 100 and 120 °C, respectively. The samples were introduced into the ion
source by direct injection at a ﬂow rate of 5 ml min  1. The raw data containing
multiple positively charged protein peaks were deconvoluted and smoothed using
MassLynx 4.1.

X-ray crystallographic data collection and reﬁnement. Puriﬁed AMSDH samples at a ﬁnal concentration of 10 mg ml  1 containing no NAD þ or 10 equiv. of
NAD þ were used to set up sitting-drop vapour diffusion crystal screening trays in
Art Robbins 96-well Intelli-Plates using an ARI Gryphon crystallization robot. The
initial crystallization conditions were obtained from PEG-Ion 1/2 (Hampton
Research) screening kits at room temperature. The screened conditions were optimized by increasing protein concentration to 40 mg ml  1 and lowering crystallization temperature to 18 °C. NAD þ -bound AMSDH crystals were obtained from
drops assembled with 1.5 ml of protein (preincubated for 10 min with 10 equiv. of
NAD þ ) mixed with 1.5 ml of a reservoir solution containing 20% polyethylene glycol
3350 and 0.2 M sodium phosphate dibasic monohydrate, pH 9.1, by hanging drop
diffusion in VDX plates (Hampton Research). Pyramid shaped crystals that diffract
up to B1.9 Å appeared overnight. The reservoir solution for crystallizing the
cofactor-free AMSDH crystals contains 12% polyethylene glycol 3350, 0.1 M sodium
formate, pH 7.0. Crystals belonging to the same space group formed within 2–3 days
with an irregular plate shape and diffracted up to B2.2 Å. NAD þ -AMSDH crystals
were used for substrate-soaking experiments. Crystals were transferred to mother
liquor solution containing B1 mM 2-HMS and incubated for 10–180 min before
ﬂash cooling in liquid nitrogen. Soaking 2-AMS as a substrate is more complicated
because of its instability. Crystallization solution containing B1.5 mM ACMS were
used for soaking. After transferring several crystals to the soaking solution (8 ml), 2 ml
of 1 mM puriﬁed ACMSD was included to catalyse the conversion of ACMS to
2-AMS. Crystals were ﬂash frozen after a 5 min-incubation. Crystallization solution
containing 20% glycerol or ethylene glycol was used as cryoprotectant. X-ray
diffraction data were collected on SER-CAT beamline 22-ID or 22-BM of the
Advanced Photon Source, Argonne National Laboratory.

Computational studies. All ground-state density functional theory calculations
were performed with Gaussian 03 Revision-E.01 at the B3LYP/6-31G* þ level of
theory38. The chemical structures were optimized using the ternary complex crystal
structure (PDB entry: 4I25) as a starting model. To calculate the isomerization
barrier, the dihedral angle about the 2–3 bond was restrained and the rest of the
molecule was optimized. For the calculations that included the guanidinium heads
of Arg120 and Arg464, the geometry was obtained from the crystal structure, and
their positions were ﬁxed while the substrate was optimized.

Ligand reﬁnement and molecular modelling. The ﬁrst AMSDH structure, the
cofactor NAD þ bound structure, was solved by the molecular replacement method
with the Advanced Molecular Replacement coupled with Auto Model Building
programs from the PHENIX software using 5-carboxymethyl-2-hydroxymuconate
semialdehyde dehydrogenase (PDB: 2D4E) as a search model, which shares 39% of
amino-acid sequence identity with P. ﬂuorescens AMSDH. The ligand-free, mutant
and ternary complex structures were solved by molecular replacement using the
reﬁned NAD þ -AMSDH as the search model. Reﬁnement was conducted using
PHENIX software34. The program Coot was used for electron density map analysis
and model building35. NAD þ /NADH, substrates 2-AMS and 2-HMS and Cyssubstrate covalent-adduct intermediate were well deﬁned and added to the model
based on the 2Fo  Fc and Fo  Fc electron density maps. Reﬁnement was assessed
as complete when the Fo  Fc electron density contained only noise. The structural
ﬁgures were generated using PyMOL software (http://www.pymol.org/).
Single-crystal spectroscopy. Electronic absorption spectra from single crystals
held at 100 K were collected at beamline X26-C of the National Synchrotron Light
Source (NSLS)36. The electronic absorption data were typically obtained between
200 and 1,000 nm with a Hamamatsu (Bridgewater, N.J.) L10290 high-power
ultraviolet–visible light source. The lamp was connected to one of several 3-m long
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